FIELD: medicine.
SUBSTANCE: invention refers to radiation synthesis nanotechnology for the creation of a low-immunogenicity agent to increase the reserved stem cell number in an organism, and can be used in regenerative medicine. The agent represents polymer immobilised hyaluronidase introduced in the dissolved low-molecular water-soluble polymer pre-exposed to ionising radiation in dosage 1-5 Mrad, to final concentration 70 UN in 1 ml.
EFFECT: invention allows producing immobilised hyaluronidase which is characterised by substantially higher ability to increase the reserved stem cell number in an organism and effective both in parenteral, and in oral introduction.
4 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF INCREASING STEM CELLS MOBILIZATION | 2009 |
|
RU2442601C2 |
| MEDICATION FOR REGENERATIVE MEDICINE | 2009 |
|
RU2406528C2 |
| HEMOSTIMULANT AND EXCITANT AND METHOD FOR HEMOPOIESIS STIMULATION | 2009 |
|
RU2414926C1 |
| HEPATOPROTECTOR | 2010 |
|
RU2444569C1 |
| AGENT FOR BODY GROWTH STIMULATION | 2011 |
|
RU2452509C1 |
| HAEMOSTIMULATING MEDICATION | 2010 |
|
RU2437675C1 |
| AGENT INTENSIFYING ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES AND DRUGS | 2009 |
|
RU2421239C1 |
| DRUG POSSESSING REGENERATIVE ACTIVITY | 2011 |
|
RU2480236C1 |
| ANALGESIC | 2011 |
|
RU2452510C1 |
| HYPOGLYCEMIC AGENT IN NON-INSULIN-DEPENDENT DIABETES MELLITUS | 2009 |
|
RU2416427C1 |
